HOME >> BIOLOGY >> NEWS
Medication reconciliation, pharmacist involvement vital to reducing medication errors, study finds

CHICAGO Obtaining complete and accurate medication histories of patients and instituting a medication reconciliation program are vital to reducing medication errors, a new study conducted at Northwestern Memorial Hospital has shown. The study demonstrated that when hospital pharmacists perform medication reconciliation, taking steps to ensure patients receive the correct medication and accurate dosage, the number of medication errors dropped and with them the potential for patient injury.

"A medication error, once in a patient's medical record, can carry-over from admission through discharge unless medication reconciliation is performed," says Kristine Gleason, who is on the hospital's Patient Safety Team and is the lead author of the study, Reconciliation of Discrepancies in Medication Histories and Admission Orders of Newly Hospitalized Patients. "Doctors, nurses, pharmacists and patients often just assume medical histories are accurate, and that's not always the case."

The study findings, published this week in the American Journal of Health-System Pharmacy, are particularly significant in light of the recent announcement by the Joint Commission on Accreditation of Healthcare Organizations that medication reconciliation for all hospital patients is one of its 2005 National Patient Safety Goals. That means medication reconciliation programs are a requirement for accreditation.

Northwestern Memorial is working toward that goal, implementing a computerized prescriber order entry (CPOE) system as part of its patient safety initiative. A previous study at Northwestern Memorial found that a combination of pharmacist involvement and a CPOE system with significant clinical decision support will likely provide the best approach to improve medication safety among patients.

Data collected by Northwestern Memorial researchers for the new study showed that in the absence of a pharmacist intervention, 22 percent of medication discrepan
'"/>

Contact: Andrew Buchanan
anbuchan@nmh.org
312-926-6503
Northwestern Memorial Hospital
16-Aug-2004


Page: 1 2 3

Related biology news :

1. Possible Dangers Of Taking Over-The-Counter Medications For Hepatitis C Patients
2. Common Anti-Viral Medication Prevents Severe Eye Herpes
3. New Medication Means New Choices For Families Dealing With Alzheimers Disease
4. Study Reviews Medication Use In Elderly Cardiac Patients After Discharge
5. Call for greater involvement of developing world scientists in fight against AIDS
6. Yale researchers shed light on B cells involvement in autoimmune diseases like lupus
7. Education, monitoring vital for sport-fish eaters
8. Life goes on without vital DNA
9. Rb2 expression could play vital role in ovarian cancer Temple University researchers find
10. Vascular access vital to pump up tissue engineering
11. Study links amyloid plaques in Alzheimers brains to genes vital to normal memory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/2/2016)... 2016   Parabon NanoLabs (Parabon) announced ... Research Office and the Defense Forensics and Biometrics ... the company,s Snapshot Kinship Inference software ... generally, defense-related DNA forensics.  Although Snapshot is best ... and ancestry from DNA evidence), it also has ...
(Date:2/1/2016)... , Feb. 1, 2016  Today, the first day ... announced plans to develop a first of its kind ... of IBM Watson. In the first application of ... (NYSE: IBM ), and Welltok will create a ... assessments with cognitive analytics, delivered on Welltok,s health optimization ...
(Date:1/27/2016)... , Jan. 27, 2016  Rite Track, Inc. a ... West Chester, Ohio announced today ... service staff, based in Austin, Texas ... ability to provide modifications, installations and technical support offerings ... CEO of PLUS, commented, "PLUS has provided world class ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... Strasbourg, France , to the US ... Strasbourg, France , to the US company Advanced Bioscience ... announce that it acted as an advisor to Transgene on ... Strasbourg, France , to the US company Advanced Bioscience ... Transgene (Euronext: TNG), a member of Institut Mérieux, is ...
(Date:2/3/2016)... , Feb. 3, 2016  With the growing ... cliff that is underway, therapies such as monoclonal ... a whole host of indications are in high ... in the development and production of these therapeutics. ... quality and high costs, novel approaches and novel ...
(Date:2/3/2016)... Denver, Colorado (PRWEB) , ... February 03, 2016 ... ... to hospitals, has established a new office dedicated to the North American healthcare ... provide turnkey solutions to healthcare facilities. The company will provide new pneumatic ...
(Date:2/3/2016)... -- Silk Therapeutics, Inc., today announced the closing of a $6 ... a total of $10.25 million in Series A funding based ... round was led by existing investor The Kraft Group of ... investors Lear Corporation and Highland Consumer Partners, as well as ... Richard Sackler , MD, with Summer Road, LLC; Erin ...
Breaking Biology Technology:
Cached News: